<DOC>
	<DOC>NCT01473069</DOC>
	<brief_summary>The purpose of this study was to determine the safety, tolerability and pharmacokinetics of sequential ascending doses of JTK-853 administered for 14 days in healthy subjects and also to determine the effect of a single dose of ketoconazole on the steady-state pharmacokinetic profile of JTK-853 and its metabolite M2 (one cohort only).</brief_summary>
	<brief_title>Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>1. Body Mass Index (BMI) ≥18.0 kg/m2 and ≤30.0 kg/m2 2. Nonsmokers or subjects who have stopped smoking at least 6 months prior to the Screening Visit 3. Female subjects must be either surgically sterile or postmenopausal 1. History or presence of cardiac disease, including a family history of longQT syndrome or unexplained sudden death 2. Have used any prescription medication, herbal product, or overthecounter (OTC) medication (except acetaminophen) within four weeks prior to Day 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>JTK-853</keyword>
	<keyword>Healthy subjects</keyword>
</DOC>